Home

CitBIO
Group photo

CitBIO – Center for Intestinal Absorption and Transport of Biopharmaceuticals – is funded by the Novo Nordisk Foundation’s Challenge Programme with a total budget of 60 mill. DKK over a six-year period up to the year 2023.

CitBIO discussion

CitBIO – Center for Intestinal Absorption and Transport of Biopharmaceuticals – is funded by the Novo Nordisk Foundation’s Challenge Programme with a total budget of 60 mill. DKK over a six-year period up to the year 2023

CitBIO

CitBIO – Center for Intestinal Absorption and Transport of Biopharmaceuticals – is funded by the Novo Nordisk Foundation’s Challenge Programme with a total budget of 60 mill. DKK over a six-year period up to the year 2023

CitBIO fun

CitBIO – Center for Intestinal Absorption and Transport of Biopharmaceuticals – is funded by the Novo Nordisk Foundation’s Challenge Programme with a total budget of 60 mill. DKK over a six-year period up to the year 2023

CitBIO – Center for Intestinal Absorption and Transport of Biopharmaceuticals – is funded by the Novo Nordisk Foundation’s Challenge Programme with a total budget of 60 mill. DKK over a six-year period up to the year 2023

CitBIO – Center for Intestinal Absorption and Transport of Biopharmaceuticals – is funded by the Novo Nordisk Foundation’s Challenge Programme with a total budget of 60 mill. DKK over a six-year period up to the year 2023

Center for Intestinal Absorption and Transport of Biopharmaceuticals

CitBIO – Center for Intestinal Absorption and Transport of Biopharmaceuticals – is funded by the Novo Nordisk Foundation with a 60 mill. DKK grant. CitBIO will run for six years up to the year 2023.

The main partners in CitBIO are Harvard Medical School (USA), Boston Children’s Hospital (USA), Monash University (Australia) and DTU Health Tech. The center is headed by Prof. Thomas L. Andresen from DTU Health Tech.

Ørsteds Plads, Building 345C
2800 Kgs. Lyngby
Denmark
https://citbio.dtu.dk/da
11 DECEMBER 2024